絞り込み

16643

広告

Etanercept With IVIg for Acute Kawasaki Disease: A Randomized Controlled Trial.

著者 Portman MA , Dahdah NS , Slee A , Olson AK , Choueiter NF , Soriano BD , Buddhe S , Altman CA ,
Pediatrics.2019 May 02 ; ():.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (16view , 0users)

Full Text Sources

Patients with Kawasaki disease can develop life-altering coronary arterial abnormalities, particularly in those resistant to intravenous immunoglobulin (IVIg) therapy. We tested the tumor necrosis factor α receptor antagonist etanercept for reducing both IVIg resistance and coronary artery (CA) disease progression.
PMID: 31048415 [PubMed - as supplied by publisher]
印刷用ページを開く Endnote用テキストダウンロード